Literature DB >> 18710250

Dose-dependent absorption, metabolism, and excretion of genistein in rats.

Siyuan Zhou1, Yuzhen Hu, Bangle Zhang, Zenghui Teng, Hongquan Gan, Zhifu Yang, Qingwei Wang, Menglei Huan, Qibing Mei.   

Abstract

Genistein (4',5,7-trihydroxyisoflavone), a naturally occurring phenolic compound, possesses well-known preventive activity in breast and prostate cancer, cardiovascular diseases, and postmenopausal problems. The aim of this study is to investigate the distribution and dose-dependent absorption, metabolism, and excretion of genistein in rats. Genistein was orally administered to rats at different doses. At various time intervals, blood, bile, and urine samples were collected and incubated with glucuronidase to hydrolyze the glucuronidated genistein. Genistein was detected by HPLC. High levels of glucuronidated genistein were detected in the plasma, bile, and urine after genistein administration. When genistein was administered to rats at 6.25, 12.5, and 50 mg x kg (-1) doses, the AUC (0- t) values for genistein were 23.5, 80.9, and 177.9 mg x min x L (-1); the oral absolute bioavailabilities were 21.9, 33.5, and 19.0%; the AUC (0- t) values of glucuronidated genistein were 173.8, 470.7, and 1721.2 mg x min x L (-1), respectively. The cumulative biliary excretion of genistein respective to each dose was 42.6 +/- 6.5, 75.2 +/- 18.9, and 126.6 +/- 34.8 microg; the cumulative biliary excretion of glucuronidated genistein was 108.5 +/- 35.2, 423.5 +/- 158.3, and 853.7 +/- 320.8 microg for each dose, respectively. The cumulative urinary excretion of genistein was 34.8 +/- 10.8, 187.3 +/- 67.0 and 213.6 +/- 30.6 microg for each dose, respectively; the cumulative levels of glucuronidated genistein excreted in the urine were 217.8 +/- 52.1, 583.1 +/- 106.9, and 1108.4 +/- 88.1 microg, respectively. These results indicated that at high doses absorption, biotransformation, and excretion of genistein occurred in a nonlinear dose-dependent manner. Therefore, the results of these pharmacokinetic studies raise important questions about the therapeutic significance of consuming large quantities of genistein, genistein analogues, or soy-based neutraceuticals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18710250     DOI: 10.1021/jf801051d

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  14 in total

Review 1.  Interaction of Isoflavones with the BCRP/ABCG2 Drug Transporter.

Authors:  Kristin M Bircsak; Lauren M Aleksunes
Journal:  Curr Drug Metab       Date:  2015       Impact factor: 3.731

2.  Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein.

Authors:  Zhen Yang; Wei Zhu; Song Gao; Taijun Yin; Wen Jiang; Ming Hu
Journal:  Drug Metab Dispos       Date:  2012-06-26       Impact factor: 3.922

3.  Pharmacokinetics and organ distribution of diarylheptanoid phytoestrogens from Curcuma comosa in rats.

Authors:  Jian Su; Kittisak Sripanidkulchai; Apichart Suksamrarn; Ying Hu; Pawinee Piyachuturawat; Bungorn Sripanidkulchai
Journal:  J Nat Med       Date:  2011-11-20       Impact factor: 2.343

4.  Excretion of tectorigenin in rat urine orally administrated at different dosages by ultra-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.

Authors:  Ziming Shi; Guozhe Zhang; Lizhu Zhao; Shen Wang; Yoshihiro Kano; Dan Yuan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-05-01       Impact factor: 2.441

5.  Absolute bioavailability of isoflavones from soy protein isolate-containing food in female BALB/c mice.

Authors:  Juan E Andrade; Nathan C Twaddle; William G Helferich; Daniel R Doerge
Journal:  J Agric Food Chem       Date:  2010-04-14       Impact factor: 5.279

6.  In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-/-) mice.

Authors:  Gracia Merino; Miriam Perez; Rebeca Real; Estefania Egido; Julio G Prieto; Ana I Alvarez
Journal:  Pharm Res       Date:  2010-07-07       Impact factor: 4.200

Review 7.  Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME.

Authors:  Zhen Yang; Kaustubh Kulkarni; Wei Zhu; Ming Hu
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

8.  Individual and combined soy isoflavones exert differential effects on metastatic cancer progression.

Authors:  Michelle M Martínez-Montemayor; Elisa Otero-Franqui; Joel Martinez; Alina De La Mota-Peynado; Luis A Cubano; Suranganie Dharmawardhane
Journal:  Clin Exp Metastasis       Date:  2010-06-02       Impact factor: 5.150

9.  In vivo metabolism of Talosin A, new isoflavonol glycoside from Kitasatospora kifunensis, in rats.

Authors:  Jong-Hwan Lim; In-Bae Song; Youn-Hwan Hwang; Myoung-Seok Kim; Jong-Woo Kim; Jin-Yong Kim; Joo Won Suh; Hyo-In Yun
Journal:  J Vet Sci       Date:  2011-06       Impact factor: 1.672

Review 10.  Enhancing the health-promoting effects of tomato fruit for biofortified food.

Authors:  Assunta Raiola; Maria Manuela Rigano; Roberta Calafiore; Luigi Frusciante; Amalia Barone
Journal:  Mediators Inflamm       Date:  2014-03-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.